Among other pulmonary biomarkers of BPD, two independent cohorts have reported increased TA levels of angiopoietin-2 (Ang-2) to be associated with increased risk of BPD and/or death (82, 83). The gene discussed is ANGPT2; the disease is bronchopulmonary dysplasia.